Drugs / HSS 3%
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01873144 Comparator | Oct 2010 → Dec 2012 | acute bronchiolitis | Ministry of Health, Spain | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HSS 3% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01873144 ↗ |
| Route | Inhaled | “Nebulization 2 mL of HSS (3%)+ epinephrine every 4h” NCT01873144 ↗ |